Caricamento...
Non-antigenic and antigenic interventions in type 1 diabetes
Type 1 diabetes (T1D) results from autoimmune destruction of the pancreatic β-cells. Current T1D therapies are exclusively focused on regulating glycemia rather than the underlying immune response. A handful of trials have sought to alter the clinical course of T1D using various broad immune-suppres...
Salvato in:
| Pubblicato in: | Hum Vaccin Immunother |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4896560/ https://ncbi.nlm.nih.gov/pubmed/24165565 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.26890 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|